NCT04219592Completed
IgG-4 Levels in Systemic Sclerosis
Comparing IgG-4 Levels in Systemic Sclerosis Patients vs. Healthy Controls
Source: ClinicalTrials.gov · Last updated 16 May 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This is an observational - non interventional study. The investigators will compare IgG4 levels of 80 healthy donors (from Israel blood bank - MDA) and 80 Systemic Sclerosis patients from Meir Medical Center.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 154 (actual)
- First submitted
- 5 Jan 2020
- Start date
- 30 May 2019
- Primary completion date
- 30 Sept 2024
- Lead sponsor
- Meir Medical Center
- Diseases
- Systemic sclerosis (scleroderma)
- NCT number
- NCT04219592
What you commit to
- Study type: Observational
- Participants enrolled: 154
- From 30 May 2019 to the primary completion date, 30 Sept 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- other chronic co-morbidities
Who the study is looking for
- SSc patients
Age in the registry: 18 years to 85 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Meir Medical Center Coordinator of this site? Confirm its status | Kfar Saba | Israel | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.